A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block.

A comparative study of 0.25% ropivacaine and 0.25% bupivacaine for brachial plexus block.

A Randomized Controlled Study of 0.5% Bupivacaine, 0.5% Ropivacaine and 0.75% Ropivacaine for Supraclavicular Brachial Plexus Block.

Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia.

Comparision between bupivacaine and ropivacaine in patients undergoing forearm surgeries under axillary brachial plexus block: a prospective randomized study.

Brachial plexus block with bupivacaine: effects of added alpha-adrenergic agonists: comparison between clonidine and epinephrine.

Postoperative analgesia comparing levobupivacaine and ropivacaine for brachial plexus block: A randomized prospective trial.

Brachial plexus block: Comparison of two different doses of clonidine added to bupivacaine.

Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block.

Efficacy of clonidine as an adjuvant to ropivacaine in supraclavicular brachial plexus block: A prospective study.

Does the addition of tramadol and ketamine to ropivacaine prolong the axillary brachial plexus block?

[Minimum effective concentration of bupivacaine for axillary brachial plexus block guided by ultrasound].

Brachial plexus block with a new local anaesthetic: 0.5 per cent ropivacaine.

Minimum effective concentration of bupivacaine for axillary brachial plexus block guided by ultrasound.

Cumulation of bupivacaine, desbutylbupivacaine and 4-hydroxybupivacaine during and after continuous interscalene brachial plexus block.

Perineural administration of dexmedetomidine in combination with ropivacaine prolongs axillary brachial plexus block.

Comparison of extradural ropivacaine and bupivacaine.

Dexmedetomidine as an adjuvant to ropivacaine in supraclavicular brachial plexus block.

Complication following a brachial plexus block.

Effect of addition of hyaluronidase to bupivacaine during axillary brachial plexus block.

The efficacy of adding dexamethasone, midazolam, or epinephrine to 0.5% bupivacaine in supraclavicular brachial plexus block.

Dexmedetomidine prolongs the effect of bupivacaine in supraclavicular brachial plexus block.

Lack of Sex Difference in Minimum Local Analgesic Concentration of Ropivacaine for Ultrasound-Guided Supraclavicular Brachial Plexus Block.

Effect of dexmedetomidine as adjuvant in ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded and randomized controlled study.

HLA-B*27:05:25 - a further HLA-B*27:05 allele with a synonymous nucleotide substitution.

A comparative study of 0.25% ropivacaine and 0.25% bupivacaine for brachial plexus block.

A Randomized Controlled Study of 0.5% Bupivacaine, 0.5% Ropivacaine and 0.75% Ropivacaine for Supraclavicular Brachial Plexus Block.

Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia.

Comparision between bupivacaine and ropivacaine in patients undergoing forearm surgeries under axillary brachial plexus block: a prospective randomized study.

Brachial plexus block with bupivacaine: effects of added alpha-adrenergic agonists: comparison between clonidine and epinephrine.

Postoperative analgesia comparing levobupivacaine and ropivacaine for brachial plexus block: A randomized prospective trial.

Brachial plexus block: Comparison of two different doses of clonidine added to bupivacaine.

Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block.

Efficacy of clonidine as an adjuvant to ropivacaine in supraclavicular brachial plexus block: A prospective study.

Does the addition of tramadol and ketamine to ropivacaine prolong the axillary brachial plexus block?

[Minimum effective concentration of bupivacaine for axillary brachial plexus block guided by ultrasound].

Brachial plexus block with a new local anaesthetic: 0.5 per cent ropivacaine.

Minimum effective concentration of bupivacaine for axillary brachial plexus block guided by ultrasound.

Cumulation of bupivacaine, desbutylbupivacaine and 4-hydroxybupivacaine during and after continuous interscalene brachial plexus block.

Perineural administration of dexmedetomidine in combination with ropivacaine prolongs axillary brachial plexus block.

Comparison of extradural ropivacaine and bupivacaine.

Dexmedetomidine as an adjuvant to ropivacaine in supraclavicular brachial plexus block.

Complication following a brachial plexus block.

Effect of addition of hyaluronidase to bupivacaine during axillary brachial plexus block.

The efficacy of adding dexamethasone, midazolam, or epinephrine to 0.5% bupivacaine in supraclavicular brachial plexus block.

Dexmedetomidine prolongs the effect of bupivacaine in supraclavicular brachial plexus block.

Lack of Sex Difference in Minimum Local Analgesic Concentration of Ropivacaine for Ultrasound-Guided Supraclavicular Brachial Plexus Block.

Effect of dexmedetomidine as adjuvant in ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded and randomized controlled study.

HLA-B27:05:25 - a further HLA-B27:05 allele with a synonymous nucleotide substitution.